Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease

European Journal of Surgery

Volumn 164, Issue 3, 1998, Pages 173-178

  Kasuga, Yoshio ^a   Kobayashi, Shinya ^a   Fujimori, Minoru ^a   Shingu, Kiyoshi ^a   Asanuma, Kazuhiko ^a   Hama, Yoshihisa ^a   Ito, Ken Ichi ^a   Maruyama, Masayuki ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Graves' disease; Postoperative antithyroid antibody; Postoperative lymphocyte subset; Postoperative thyroid function; Subtotal thyroidectomy

Indexed keywords

HLA DR ANTIGEN; IMMUNOGLOBULIN ANTIBODY;

ANTIBODY TITER; ARTICLE; EUTHYROIDISM; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; SUBTOTAL THYROIDECTOMY; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ANTIGENS, CD; AUTOANTIBODIES; CASE-CONTROL STUDIES; CD4-CD8 RATIO; CHI-SQUARE DISTRIBUTION; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; MALE; PROGNOSIS; RECEPTORS, THYROTROPIN; RECURRENCE; RETROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROID HORMONES; THYROIDECTOMY;

EID: 0031970135     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241598750004607     Document Type: Article

References (23)

1. Burman KD, Baker JR. Immune mechanism in Graves' disease. Endocrinol Rev 1985; 6: 183-232.
2. Clark OH. Hyperthyroidism. In: Clark OH, ed. Endocrine surgery of the thyroid and parathyroid glands. St Louis: CV Mosby, 1985: 120-143.
3. Cooper DS. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, eds. The Thyroid. 6th ed. Philadelphia: JB Lippincott, 1991: 887-916.
4. Creagh FM, Teece M, Williams S, et al. An analysis of thyrotropin receptor binding and thyroid stimulating in a series of Graves' sera. Clin Endocrinol 1985; 23: 395-404.
5. DeGroot LJ, Larsen PR, Refetoff S, et al. The thyroid gland and its disease. 2nd ed. New York: John Wiley, 1984: 399-453.
6. Harada T, Shimaoka K, Mimura T, et al. Current treatment of Graves' disease. Surg Clin North Am 1987; 67: 299-302.
7. Hedley AJ, Bewsher PD, Jones SJ, et al. Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism. Br J Surg 1983; 70: 740-743.
8. Jörtsö E, Lennquist S, Lundstöm B, et al. The influence of remnant size, antithyroid antibodies, thyroid morphology and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism. World J Surg 1987; 11: 365-371.
9. Kaplan EL. Thyroid and parathyroid. In: Schwartz SI, Spencer GT, Storer EH, et al. Principles of surgery. New York: McGraw-Hill, 1984: 545-635.
10. Kasuga Y, Sugenoya A, Kobayashi S, et al. TSH-binding inhibitory immunoglobulin (TBII) in thyroidal venous blood and histological grade of intrathyroidal lymphocyte appearance in Graves' disease. Endocrinol Jpn 1989; 36: 775-779.
11. Kasuga Y, Sugenoya A, Kobayashi S, et al. Clinical evaluation of the response to surgical treatment of Graves' disease. Surg Gynecol Obstet 1990; 170: 327-330.
12. Kasuga Y, Sugenoya A, Kobayashi S, et al. Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for Graves' disease. J Am Coll Surg 1994; 178: 589-594.
13. Kuma K, Matsuzuka F, Kobayashi A, et al. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction. Am J Med Sci 1991; 302: 8-12.
14. Makiuchi M, Miyakawa M, Sugenoya A, Furihata R. An evaluation of several prognostic factors in the surgical treatment for thyrotoxicosis. Surg Gynecol Obstet 1981; 152: 639-641.
15. Michie W. Whither thyrotoxicosis? Br J Surg 1975; 62: 673-682.
16. Mori Y, Matoba N, Miura S, et al. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease. World J Surg 1992; 16: 647-653.
17. Okamoto T, Fujimoto Y, Obara T, et al. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease. World J Surg 1992; 16: 690-696.
18. Olsen W, Nishiyama R, Graber L. Thyroidectomy for hyperthyroidism. Arch Surg 1970; 101: 175.
19. Reinherz EL, Kung PC, Goldstein G, et al. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA 1980; 77: 1588-1600.
20. Roeher HD, Wahl R, Goretzki P, Branscheid D. Surgery for hyperthyroidism. Ann Chir Gynaecol 1983; 72: 101-104.
21. Southgate K, Creagh J, Teece M, et al. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 1984; 20: 539-543.
22. Sugino K, Mimura T, Toshima K, et al. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for postoperative thyroid dysfunction. J Endocrinol Invest 1993; 16: 195-199.
23. Volpé R. Immunology of human thyroid disease. In: Volpé R, ed. Autoimmune disease of the endocrine system. Boca Raton: CRC Press, 1990: 73-239.